Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather J Landau

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Hematology/Oncology Clinics of North America|October 25, 2020
Solid Organ TransplantationSusan Bal, Heather J Landau
Hematology. American Society of Hematology. Education Program|December 5, 2025
Monoclonal gammopathy of renal significance from a hematologic perspectiveEugene Brailovski, Insara S Jaffer, Heather J Landau
American Journal of Hematology|September 21, 2016
Organ response in patients with AL amyloidosis treated with NEOD001, an amyloid-directed monoclonal antibodyMorie A Gertz, Heather J Landau, Brendan M Weiss
Haematologica|September 29, 2018
Novel iatrogenic amyloidosis caused by peptide drug liraglutide: a clinical mimic of AL amyloidosisCarlo O Martins, Cecilia Lezcano, San S Yi, et al.
Blood Advances|July 20, 2022
Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosisCara A Rosenbaum, Umut Özbek, Larysa Sanchez, et al.
American Journal of Hematology|October 17, 2020
Involved free light chains <10 mg/L with treatment predict better outcomes in systemic light-chain amyloidosisAmandeep Godara, Denis Toskic, Jack Albanese, et al.
Kidney Medicine|August 5, 2024
Chimeric Antigen Receptor (CAR) T-Cell Therapy Use in Patients with Multiple Myeloma and Kidney Failure on Maintenance Hemodialysis: A Report of 2 CasesWai Lun Will Pak, Natalie A Brumwell, Charlene C Kabel, et al.
Molecular Cancer Therapeutics|June 2, 2012
The checkpoint kinase inhibitor AZD7762 potentiates chemotherapy-induced apoptosis of p53-mutated multiple myeloma cellsHeather J Landau, Samuel C McNeely, Jayasree S Nair, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 8, 2017
Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell TransplantationShawn C Pun, Heather J Landau, Elyn R Riedel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 20, 2020
Pilot Study of Telehealth Evaluations in Patients Undergoing Hematopoietic Cell TransplantationMariam T Nawas, Heather J Landau, Craig S Sauter, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Hematology/Oncology Clinics of North America|October 25, 2020
Solid Organ TransplantationSusan Bal, Heather J Landau
Hematology. American Society of Hematology. Education Program|December 5, 2025
Monoclonal gammopathy of renal significance from a hematologic perspectiveEugene Brailovski, Insara S Jaffer, Heather J Landau
American Journal of Hematology|September 21, 2016
Organ response in patients with AL amyloidosis treated with NEOD001, an amyloid-directed monoclonal antibodyMorie A Gertz, Heather J Landau, Brendan M Weiss
Haematologica|September 29, 2018
Novel iatrogenic amyloidosis caused by peptide drug liraglutide: a clinical mimic of AL amyloidosisCarlo O Martins, Cecilia Lezcano, San S Yi, et al.
Blood Advances|July 20, 2022
Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosisCara A Rosenbaum, Umut Özbek, Larysa Sanchez, et al.
American Journal of Hematology|October 17, 2020
Involved free light chains <10 mg/L with treatment predict better outcomes in systemic light-chain amyloidosisAmandeep Godara, Denis Toskic, Jack Albanese, et al.
Kidney Medicine|August 5, 2024
Chimeric Antigen Receptor (CAR) T-Cell Therapy Use in Patients with Multiple Myeloma and Kidney Failure on Maintenance Hemodialysis: A Report of 2 CasesWai Lun Will Pak, Natalie A Brumwell, Charlene C Kabel, et al.
Molecular Cancer Therapeutics|June 2, 2012
The checkpoint kinase inhibitor AZD7762 potentiates chemotherapy-induced apoptosis of p53-mutated multiple myeloma cellsHeather J Landau, Samuel C McNeely, Jayasree S Nair, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 8, 2017
Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell TransplantationShawn C Pun, Heather J Landau, Elyn R Riedel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 20, 2020
Pilot Study of Telehealth Evaluations in Patients Undergoing Hematopoietic Cell TransplantationMariam T Nawas, Heather J Landau, Craig S Sauter, et al.
Pageof 7